Enhanced External Counterpulsation (EECP)

DEVICE4 trials

Sponsors

Sun Yat-sen University, David Grant U.S. Air Force Medical Center, Chi-Ming Chu, Nanjing Medical University

Conditions

AtherosclerosisCardiac Force IndexCardiac OutputCardio-pulmonary BypassCardiogenic Shock AcuteCardiovascular DiseaseCongestive Heart Failure ChronicCoronary Heart Disease (CHD)

Unknown Phase

Effect of Enhanced External Counterpulsation (EECP) on Subclinical Atherosclerosis

CompletedNCT01106495

Sun Yat-sen UniversityAtherosclerosis

Start: 2010-05-31End: 2020-01-31Updated: 2020-11-02

Impact of Enhanced External Counterpulsation (EECP) on VO2 MAX

WithdrawnNCT02517671

David Grant U.S. Air Force Medical CenterCardiovascular Disease, Pulmonary Disease

Start: 2015-01-31End: 2017-10-07Updated: 2018-03-27

Impact of Enhanced External Counterpulsation (EECP) on Cardiac Force Index

Chi-Ming ChuCardiac Force Index, Cardiac Output, Enhanced External Counterpulsation (EECP)

Start: 2022-02-22End: 2023-12-31Target: 10Updated: 2022-02-23

Protective Effect of EECP Against Negative Inflammatory Response and Organ Dysfunction After Cardiovascular Surgery

Not yet recruitingNCT06728605

Nanjing Medical UniversityCardiogenic Shock Acute, Cardio-pulmonary Bypass, Congestive Heart Failure Chronic +1

Start: 2025-12-31End: 2025-12-31Target: 400Updated: 2024-12-11